Bruce D Walker
Bruce D Walker
Director, Ragon Institute of MGH, MIT and Harvard
Verified email at
Cited by
Cited by
Hepatitis C virus infection
GM Lauer, BD Walker
New England journal of medicine 345 (1), 41-52, 2001
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
CL Day, DE Kaufmann, P Kiepiela, JA Brown, ES Moodley, S Reddy, ...
Nature 443 (7109), 350-354, 2006
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
D Finzi, J Blankson, JD Siliciano, JB Margolick, K Chadwick, T Pierson, ...
Nature medicine 5 (5), 512-517, 1999
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
ES Rosenberg, JM Billingsley, AM Caliendo, SL Boswell, PE Sax, ...
Science 278 (5342), 1447-1450, 1997
Analysis of successful immune responses in persons infected with hepatitis C virus
F Lechner, DKH Wong, PR Dunbar, R Chapman, RT Chung, ...
The Journal of experimental medicine 191 (9), 1499-1512, 2000
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
KL Collins, BK Chen, SA Kalams, BD Walker, D Baltimore
Nature 391 (6665), 397-401, 1998
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding
JF Scheid, H Mouquet, B Ueberheide, R Diskin, F Klein, TYK Oliveira, ...
Science 333 (6049), 1633-1637, 2011
Immune control of HIV-1 after early treatment of acute infection
ES Rosenberg, M Altfeld, SH Poon, MN Phillips, BM Wilkes, RL Eldridge, ...
Nature 407 (6803), 523-526, 2000
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
P Kiepiela, K Ngumbela, C Thobakgale, D Ramduth, I Honeyborne, ...
Nature medicine 13 (1), 46-53, 2007
Acute human immunodeficiency virus type 1 infection
JO Kahn, BD Walker
New England Journal of Medicine 339 (1), 33-39, 1998
Persistence and evolution of SARS-CoV-2 in an immunocompromised host
B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ...
New England Journal of Medicine 383 (23), 2291-2293, 2020
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
JF Scheid, H Mouquet, N Feldhahn, MS Seaman, K Velinzon, J Pietzsch, ...
Nature 458 (7238), 636-640, 2009
HIV evolution: CTL escape mutation and reversion after transmission
AJ Leslie, KJ Pfafferott, P Chetty, R Draenert, MM Addo, M Feeney, ...
Nature medicine 10 (3), 282-289, 2004
HIV-specific cytotoxic T lymphocytes in seropositive individuals
BD Walker, S Chakrabarti, B Moss, TJ Paradis, T Flynn, AG Durno, ...
Nature 328 (6128), 345-348, 1987
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ...
Nature 432 (7018), 769-775, 2004
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy
SG Deeks, BD Walker
Immunity 27 (3), 406-416, 2007
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
MP Martin, Y Qi, X Gao, E Yamada, JN Martin, F Pereyra, S Colombo, ...
Nature genetics 39 (6), 733-740, 2007
SARS-CoV-2 viral load is associated with increased disease severity and mortality
J Fajnzylber, J Regan, K Coxen, H Corry, C Wong, A Rosenthal, D Worrall, ...
Nature communications 11 (1), 5493, 2020
The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
SA Kalams, BD Walker
The Journal of experimental medicine 188 (12), 2199-2204, 1998
Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly …
MM Addo, XG Yu, A Rathod, D Cohen, RL Eldridge, D Strick, ...
Journal of virology 77 (3), 2081-2092, 2003
The system can't perform the operation now. Try again later.
Articles 1–20